Patent invalidity and infringement ruling, the first handed down by new High Court judge, Meade J, has several important takeaways for pharma patent litigators, write Gareth Morgan and Chris Dixon of CMS Cameron McKenna Nabarro.
Patent invalidity and infringement ruling, the first handed down by new High Court judge, Meade J, has several important takeaways for pharma patent litigators, write Gareth Morgan and Chris Dixon of CMS Cameron McKenna Nabarro.